[1]
Tronieri, J.S., Wadden, T., Sugimoto, D., T. Lund, M., Auerbach, P., Endahl, L., Rubino, D. and Pasamba, C. 2022. WEIGHT LOSS WITH LIRAGLUTIDE 3.0 mg VERSUS PLACEBO FOR INDIVIDUALS WHO ADHERE TO THE TRIAL DRUG: A SECONDARY ANALYSIS FROM SCALE IBT. Journal of the ASEAN Federation of Endocrine Societies. 34, 2 (Jun. 2022), 46–47.